Loading...
Fuji Pharma Co., Ltd.
4554.T•JPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥1391.00
¥-1.00(-0.07%)
Fuji Pharma Co., Ltd. (4554.T) Financial Performance & Income Statement Overview
Analyze Fuji Pharma Co., Ltd. (4554.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Revenue Growth
12.84%
↑ 12.84%
Operating Income Growth
0.57%
↑ 0.57%
Net Income Growth
78.92%
↑ 78.92%
Operating Cash Flow Growth
116.54%
↑ 116.54%
Operating Margin
9.71%
↑ 9.71%
Gross Margin
39.92%
↑ 39.92%
Net Profit Margin
6.50%
↑ 6.50%
ROE
6.90%
↑ 6.90%
ROIC
7.59%
↑ 7.59%
Fuji Pharma Co., Ltd. (4554.T) Income Statement & Financial Overview
View the income breakdown for Fuji Pharma Co., Ltd. 4554.T across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $11.10B | $13.00B | $12.98B | $11.77B |
| Cost of Revenue | $6.51B | $7.70B | $7.65B | $7.57B |
| Gross Profit | $4.58B | $5.30B | $5.33B | $4.28B |
| Gross Profit Ratio | $0.41 | $0.41 | $0.41 | $0.36 |
| R&D Expenses | $618.00M | $745.00M | $901.00M | $774.00M |
| SG&A Expenses | $2.92B | $3.22B | $2.68B | $2.65B |
| Operating Expenses | $3.53B | $4.05B | $3.67B | $3.51B |
| Total Costs & Expenses | $10.04B | $11.75B | $11.32B | $10.99B |
| Interest Income | $3.00M | $0.00 | $0.00 | $1.00M |
| Interest Expense | $66.00M | $76.00M | $59.00M | $54.00M |
| Depreciation & Amortization | $979.00M | $920.00M | $920.00M | $755.75M |
| EBITDA | $1.43B | $2.17B | $2.58B | $1.53B |
| EBITDA Ratio | $0.13 | $0.17 | $0.20 | $0.13 |
| Operating Income | $1.05B | $1.25B | $1.67B | $772.00M |
| Operating Income Ratio | $0.09 | $0.10 | $0.13 | $0.07 |
| Other Income/Expenses (Net) | -$673.00M | $120.00M | -$210.00M | $20.00M |
| Income Before Tax | $379.00M | $1.37B | $1.46B | $792.00M |
| Income Before Tax Ratio | $0.03 | $0.11 | $0.11 | $0.07 |
| Income Tax Expense | $83.00M | $381.00M | $219.00M | $139.00M |
| Net Income | $296.00M | $991.00M | $1.24B | $653.00M |
| Net Income Ratio | $0.03 | $0.08 | $0.10 | $0.06 |
| EPS | $12.12 | $40.74 | $50.84 | $26.86 |
| Diluted EPS | $12.12 | $40.74 | $50.84 | $26.86 |
| Weighted Avg Shares Outstanding | $24.43M | $24.32M | $24.31M | $24.31M |
| Weighted Avg Shares Outstanding (Diluted) | $24.43M | $24.32M | $24.31M | $24.31M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan